arrow
F

Fabien Vincent

Pfizer
H指数:25
被引数:3,917

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of an ITK and TRK kinase inhibitor for the potential topical treatment of atopic dermatitis

发现一种ITK和TRK激酶抑制剂,用于特应性皮炎的潜在局部治疗

2026-03-090
OAAI
Peptidylarginine Deiminase (PAD) Inhibitor Optimization through Displacement of a Trapped Water Molecule

通过置换一个被困水分子优化肽精氨酸脱亚胺酶(PAD)抑制剂

2025-07-090
PRE
Inhibiting peptidylarginine deiminases (PAD1-4) by targeting a Ca2+ dependent allosteric binding site

通过靶向一个Ca2+依赖性的别构结合位点抑制肽基精氨酸脱亚胺酶(PAD1-4)

2025-05-160
OA
Discovery, Characterization, and Structure of a Cell Active PAD2 Inhibitor Acting through a Novel Allosteric Mechanism
2024-09-240
PRE
Structural basis for CCR6 modulation by allosteric antagonists
2024-08-312
OA
A Novel C-C Chemoattractant Cytokine (Chemokine) Receptor 6 (CCR6) Antagonist (PF-07054894) Distinguishes between Homologous Chemokine Receptors, Increases Basal Circulating CCR6+T Cells, and Ameliorates Interleukin-23-Induced Skin Inflammation
2023-07-018
OAAI
Discovery of a Series of Pyrimidine Carboxamides as Inhibitors of Vanin-1

一系列嘧啶甲酰胺类Vanin-1抑制剂的发现

2021-12-309
PREAI
Human amyotrophic lateral sclerosis excitability phenotype screen: Target discovery and validation
2021-06-0136
OAAI
Design and optimization of a series of 4-(3-azabicyclo[3.1.0]hexan-3-yl) pyrimidin-2-amines: Dual inhibitors of TYK2 and JAK1
2020-05-0115
OAAI
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-(1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
2018-08-16144
PREAI
Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors
2018-02-0133
PREAI